Donald Notman
Directeur Financier/CFO chez OCULAR THERAPEUTIX, INC.
Fortune : 328 289 $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Jeffrey S. Heier | M | 63 | 9 ans | |
| Charles Warden | M | 55 | 16 ans | |
| Scott Corning | M | - | 14 ans | |
| Richard Lindstrom | M | 76 | 12 ans | |
| Merilee Raines | F | 68 | 3 ans | |
| Leslie Williams | F | 64 | 5 ans | |
| Seung Suh Hong | M | 66 | 5 ans | |
| Adrienne Graves | M | 69 | 1 ans | |
| Karen-Leigh Edwards | M | - | 3 ans | |
| Tracy Smith | F | - | 4 ans | |
| Pravin Dugel | M | 60 | - | |
| Philip Strassburger | M | 64 | 4 ans | |
| Peter K. Kaiser | M | - | - | |
| Pauline Jen Ryan | F | - | - | |
| Christopher White | M | 62 | 5 ans | |
| Peter Jarrett | M | - | 17 ans | |
| Sanjay Nayak | M | 54 | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Amarpreet S. Sawhney | M | 57 | 13 ans | |
| Antony Mattessich | M | 57 | 7 ans | |
| Jim O'Shea | M | 74 | 4 ans | |
| Bruce Peacock | M | 72 | 8 ans | |
| Joseph Zakrzewski | M | 60 |
Thrasos Therapeutics, Inc.
 Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | - |
| George Migausky | M | 69 | - | |
| Kevin Hanley | M | 62 | 2 ans | |
| Patricia Kitchen | F | 46 | 2 ans | |
| Chad Brines | M | - | 4 ans | |
| Jonathan M. Sparks | M | - | - | |
| Nicole Carta | F | - | - | |
| Naymisha Patel | F | - | - | |
| Rabia Ozden | M | 56 | 3 ans | |
| Daniel M. Bollag | M | 63 | 2 ans | |
| Michael H. Goldstein | M | 57 | - | |
| Gaétan Gravel | M | - |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | - |
| Jaswinder S. Chadha | M | 56 | 6 ans | |
| Amar Sawhney | M | - | 2 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 33 | 94,29% |
| Canada | 2 | 5,71% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Donald Notman
- Réseau Personnel
